This page aims to summarise the Swedish companies (AB) who are #1 developing ATMPs, #2 providing services for ATMPs, #3 providing products for ATMPs.
If you are not listed and have relevant activities please contact us!
The vast majority of Swedish companies are developing Gene Therapy Medicinal Products (GTMP). However, keep in mind that cells that are genetically modified in-vitro and then delivered to a patient are classified as ex-vivo GTMPs not sCTMPs. Check out our What are ATMPs page to see why some ATMP technologies may be classified as sCTMP, GTMP or TEP. There are Swedish companies developing gene therapies based on synthetic oligonucleotides but these are not classified as ATMPs.